{"entity":{"type":"insider","cik":"0001630109","url":"/insider/0001630109","json_url":"/insider/0001630109.json","name":"Slakter Jason Scott","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":109,"n_filings":11,"first":"2015-02-10","last":"2017-04-13","span_basis":"filed_date"},"name_variants":[{"name":"Slakter Jason Scott","source":"filing","n_filings":11,"first_seen":"2015-02-10","last_seen":"2017-04-13"}],"transactions":[{"id":4676533,"accession":"0001387131-17-002057","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-17-002057","line_url":"/filing/0001387131-17-002057#line-1","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"Ohr Pharmaceutical Inc","issuer_ticker":"OHRP","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001630109","owner_name":"Slakter Jason Scott","owner_display_name":"Slakter Jason Scott","owner_url":"/insider/0001630109","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":142858.0,"shares_display":"142,858","price_per_share":0.7,"price_display":"0.70","price_state":"stated","total_value":100000.6,"total_display":"100,000.60","total_whole":"100,001","shares_owned_after":1067898.0,"shares_owned_after_display":"1,067,898","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-10","filed_date":"2017-04-13","scope":"insider"},{"id":2393006,"accession":"0001387131-16-005874","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001387131-16-005874","line_url":"/filing/0001387131-16-005874","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"Ohr Pharmaceutical Inc","issuer_ticker":"OHRP","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001630109","owner_name":"Slakter Jason Scott","owner_display_name":"Slakter Jason Scott","owner_url":"/insider/0001630109","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8786.0,"shares_display":"8,786","price_per_share":2.8454017755520145,"price_display":"2.85","price_state":"stated","total_value":24999.7,"total_display":"24,999.70","total_whole":"25,000","shares_owned_after":924489.0,"shares_owned_after_display":"924,489","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-06-20","filed_date":"2016-06-21","scope":"insider","n_lines":6},{"id":2300757,"accession":"0001387131-16-005689","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001387131-16-005689","line_url":"/filing/0001387131-16-005689","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"Ohr Pharmaceutical Inc","issuer_ticker":"OHRP","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001630109","owner_name":"Slakter Jason Scott","owner_display_name":"Slakter Jason Scott","owner_url":"/insider/0001630109","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3682.0,"shares_display":"3,682","price_per_share":3.1088131450298753,"price_display":"3.11","price_state":"stated","total_value":11446.65,"total_display":"11,446.65","total_whole":"11,447","shares_owned_after":916254.0,"shares_owned_after_display":"916,254","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-25","filed_date":"2016-05-26","scope":"insider","n_lines":6},{"id":2897702,"accession":"0001387131-16-005686","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0001387131-16-005686","line_url":"/filing/0001387131-16-005686","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"Ohr Pharmaceutical Inc","issuer_ticker":"OHRP","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001630109","owner_name":"Slakter Jason Scott","owner_display_name":"Slakter Jason Scott","owner_url":"/insider/0001630109","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7503.0,"shares_display":"7,503","price_per_share":3.0891255764360923,"price_display":"3.09","price_state":"stated","total_value":23177.7092,"total_display":"23,177.71","total_whole":"23,178","shares_owned_after":911364.0,"shares_owned_after_display":"911,364","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-24","filed_date":"2016-05-25","scope":"insider","n_lines":13},{"id":2897651,"accession":"0001387131-16-005686","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001387131-16-005686","line_url":"/filing/0001387131-16-005686","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"Ohr Pharmaceutical Inc","issuer_ticker":"OHRP","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001630109","owner_name":"Slakter Jason Scott","owner_display_name":"Slakter Jason Scott","owner_url":"/insider/0001630109","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20565.0,"shares_display":"20,565","price_per_share":3.1704033552151714,"price_display":"3.17","price_state":"stated","total_value":65199.345,"total_display":"65,199.34","total_whole":"65,199","shares_owned_after":897579.0,"shares_owned_after_display":"897,579","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-23","filed_date":"2016-05-25","scope":"insider","n_lines":14},{"id":3303844,"accession":"0001387131-16-004943","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001387131-16-004943","line_url":"/filing/0001387131-16-004943#line-1","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"Ohr Pharmaceutical Inc","issuer_ticker":"OHRP","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001630109","owner_name":"Slakter Jason Scott","owner_display_name":"Slakter Jason Scott","owner_url":"/insider/0001630109","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6250.0,"shares_display":"6,250","price_per_share":3.35,"price_display":"3.35","price_state":"stated","total_value":20937.5,"total_display":"20,937.50","total_whole":"20,938","shares_owned_after":884504.0,"shares_owned_after_display":"884,504","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-11","filed_date":"2016-04-12","scope":"insider"},{"id":2221243,"accession":"0001387131-16-004517","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001387131-16-004517","line_url":"/filing/0001387131-16-004517#line-16","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"Ohr Pharmaceutical Inc","issuer_ticker":"OHRP","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001630109","owner_name":"Slakter Jason Scott","owner_display_name":"Slakter Jason Scott","owner_url":"/insider/0001630109","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2200.0,"shares_display":"2,200","price_per_share":3.63,"price_display":"3.63","price_state":"stated","total_value":7986.0,"total_display":"7,986.00","total_whole":"7,986","shares_owned_after":876554.0,"shares_owned_after_display":"876,554","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-07","filed_date":"2016-03-09","scope":"insider"},{"id":2221238,"accession":"0001387131-16-004517","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001387131-16-004517","line_url":"/filing/0001387131-16-004517#line-15","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"Ohr Pharmaceutical Inc","issuer_ticker":"OHRP","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001630109","owner_name":"Slakter Jason Scott","owner_display_name":"Slakter Jason Scott","owner_url":"/insider/0001630109","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1523.0,"shares_display":"1,523","price_per_share":3.7,"price_display":"3.70","price_state":"stated","total_value":5635.1,"total_display":"5,635.10","total_whole":"5,635","shares_owned_after":873527.0,"shares_owned_after_display":"873,527","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-07","filed_date":"2016-03-09","scope":"insider"},{"id":2221231,"accession":"0001387131-16-004517","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001387131-16-004517","line_url":"/filing/0001387131-16-004517#line-14","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"Ohr Pharmaceutical Inc","issuer_ticker":"OHRP","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001630109","owner_name":"Slakter Jason Scott","owner_display_name":"Slakter Jason Scott","owner_url":"/insider/0001630109","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":3.6,"price_display":"3.60","price_state":"stated","total_value":1440.0,"total_display":"1,440.00","total_whole":"1,440","shares_owned_after":877254.0,"shares_owned_after_display":"877,254","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-07","filed_date":"2016-03-09","scope":"insider"},{"id":2221226,"accession":"0001387131-16-004517","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001387131-16-004517","line_url":"/filing/0001387131-16-004517#line-13","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"Ohr Pharmaceutical Inc","issuer_ticker":"OHRP","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001630109","owner_name":"Slakter Jason Scott","owner_display_name":"Slakter Jason Scott","owner_url":"/insider/0001630109","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":327.0,"shares_display":"327","price_per_share":3.66,"price_display":"3.66","price_state":"stated","total_value":1196.82,"total_display":"1,196.82","total_whole":"1,197","shares_owned_after":873854.0,"shares_owned_after_display":"873,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-07","filed_date":"2016-03-09","scope":"insider"},{"id":2221220,"accession":"0001387131-16-004517","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001387131-16-004517","line_url":"/filing/0001387131-16-004517#line-12","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"Ohr Pharmaceutical Inc","issuer_ticker":"OHRP","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001630109","owner_name":"Slakter Jason Scott","owner_display_name":"Slakter Jason Scott","owner_url":"/insider/0001630109","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":3.65,"price_display":"3.65","price_state":"stated","total_value":1095.0,"total_display":"1,095.00","total_whole":"1,095","shares_owned_after":874154.0,"shares_owned_after_display":"874,154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-07","filed_date":"2016-03-09","scope":"insider"},{"id":2221215,"accession":"0001387131-16-004517","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001387131-16-004517","line_url":"/filing/0001387131-16-004517#line-11","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"Ohr Pharmaceutical Inc","issuer_ticker":"OHRP","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001630109","owner_name":"Slakter Jason Scott","owner_display_name":"Slakter Jason Scott","owner_url":"/insider/0001630109","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":3.61,"price_display":"3.61","price_state":"stated","total_value":1083.0,"total_display":"1,083.00","total_whole":"1,083","shares_owned_after":876854.0,"shares_owned_after_display":"876,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-07","filed_date":"2016-03-09","scope":"insider"},{"id":2221208,"accession":"0001387131-16-004517","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001387131-16-004517","line_url":"/filing/0001387131-16-004517#line-10","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"Ohr Pharmaceutical Inc","issuer_ticker":"OHRP","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001630109","owner_name":"Slakter Jason Scott","owner_display_name":"Slakter Jason Scott","owner_url":"/insider/0001630109","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":3.64,"price_display":"3.64","price_state":"stated","total_value":728.0,"total_display":"728.00","total_whole":"728","shares_owned_after":874354.0,"shares_owned_after_display":"874,354","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-07","filed_date":"2016-03-09","scope":"insider"},{"id":2221202,"accession":"0001387131-16-004517","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001387131-16-004517","line_url":"/filing/0001387131-16-004517#line-9","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"Ohr Pharmaceutical Inc","issuer_ticker":"OHRP","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001630109","owner_name":"Slakter Jason Scott","owner_display_name":"Slakter Jason Scott","owner_url":"/insider/0001630109","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200.0,"shares_display":"200","price_per_share":3.46,"price_display":"3.46","price_state":"stated","total_value":692.0,"total_display":"692.00","total_whole":"692","shares_owned_after":878054.0,"shares_owned_after_display":"878,054","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-07","filed_date":"2016-03-09","scope":"insider"},{"id":2221196,"accession":"0001387131-16-004517","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001387131-16-004517","line_url":"/filing/0001387131-16-004517#line-8","is_derivative":false,"issuer_cik":"0001173281","issuer_name":"Ohr Pharmaceutical Inc","issuer_ticker":"OHRP","issuer_name_source":null,"issuer_url":"/issuer/0001173281","owner_cik":"0001630109","owner_name":"Slakter Jason Scott","owner_display_name":"Slakter Jason Scott","owner_url":"/insider/0001630109","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":3.59,"price_display":"3.59","price_state":"stated","total_value":359.0,"total_display":"359.00","total_whole":"359","shares_owned_after":877354.0,"shares_owned_after_display":"877,354","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-07","filed_date":"2016-03-09","scope":"insider"}],"collapsed":true,"next_cursor":"2016-03-07|2221196","ledger_fault":false,"count":{"value":109,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":109,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":109},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001173281","name":"Ohr Pharmaceutical Inc","url":"/issuer/0001173281","role":"Director, Officer (Chief Executive Officer)","n_filings":11,"first_seen":"2015-02-10","last_seen":"2017-04-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001630109","retrieved_at":"2026-08-22T21:51:16+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}